Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,897
Closed -$743K 3401
2022
Q2
$743K Sell
1,897
-1,725
-48% -$719K ﹤0.01% 2605
2022
Q1
$3.45M Buy
+3,622
New +$4.62M 0.01% 1686
2021
Q2
Sell
-157
Closed -$711K 2708
2021
Q1
$711K Sell
157
-298
-65% -$1.25M ﹤0.01% 1804
2020
Q4
$1.49M Buy
+455
New +$546K 0.01% 1056
2017
Q1
Sell
-221
Closed -$1.36M 390
2016
Q4
$1.36M Sell
221
-105
-32% -$631K 0.01% 716
2016
Q3
$1.7M Buy
+326
New +$1.19M 0.01% 630

Other funds holding CRIS

Marshall Wace's CRIS Position: Q3 2022 in Review

Marshall Wace sold out of Curis (CRIS) in Q3 2022, closing a stake of 1,897 shares — an estimated $743K sold.

Marshall Wace first reported a position in CRIS in Q3 2016 and held it in 6 quarters. The position peaked at $3.45M in Q1 2022. 71 funds tracked by Wall St. Rank hold CRIS as of Q3 2022.

  • Marshall Wace reported no remaining Curis position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 1,897 Curis shares in Q3 2022, an estimated $743K.
  • Marshall Wace first reported a position in Curis in Q3 2016 and held it in 6 quarters.
  • Marshall Wace's Curis position peaked at $3.45M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held Curis as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.